Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
This study has finished and is no longer accepting participants.
In Chapel Hill
Randomized Trial of a Smoking Cessation Program for Persons With SMI
This study has finished and is no longer accepting participants.
Multiple locations, including Washington D.C.
Double Blind Placebo Controlled Investigation of Amantadine for Retarding Weight Gain in First Episode Adlt Psychotic Subjects Beginning Therapy With Olanzapine.
This study has finished and is no longer accepting participants.
In Chapel HillEffect of Vitamin D Supplementation on the Metabolic Abnormalities of Second Generation Antipsychotics in Children and Adolescents
This study has finished and is no longer accepting participants.
In WorcesterA pilot study examining whether or not the provision of a 6 month peer support program commencing 3 months prior to discharge from a specialist first-episode psychosis treatment center can improve treatment adherence and other outcomes among young people
This study ended early.
Location not clearly listedA pilot study of a Critical-Time Intervention (CTI) for mentally ill prisoners exiting custody, to improve mental health and criminal justice outcomes
This study has finished and is no longer accepting participants.
In AustraliaA randomised controlled trial on the effect of problem-solving based bibliotherapy in improving general wellbeing and lowering distress in primary caregivers of family members with first-episode psychosis.
This study has finished and is no longer accepting participants.
In AustraliaA randomised placebo controlled trial of intensive psychosocial treatment plus or minus anti-psychotic medication for first episode psychosis with low-risk of self-harm or aggression to evaluate the impact on functioning and symptomatology. The STAGES Study: Staged Treatment and Acceptability Guidelines in Early Psychosis
This study has finished and is no longer accepting participants.
In AustraliaAntipsychotic discontinuation in first-episode never-treated psychosis: an open randomised clinical trial involving Haloperidol, Olanzapine, Quetiapine, Risperidone, and Ziprasidone
This study has finished and is no longer accepting participants.
In SpainIndividualised metacognitive therapy (MCT+) for delusions: A randomized controlled rater-blind study
This study has finished and is no longer accepting participants.
Multiple locations, including Elizabeth ValeA study investigating the influence of eicosapentanoic acid (EPA) supplementation in First Episode Psychotic Patients on clinical outcome and cognition
This study has finished and is no longer accepting participants.
Location not clearly listedIn smokers with psychotic disorders, is an intervention consisting of nicotine replacement therapy (NRT) and motivational interviewing and cognitive-behaviour therapy (MICBT) and contingency management (CM) as or more effective as a one-session intervention followed by NRT plus brief contact for reduction of cardiovascular disease (CVD) risk and smoking cessation?
This study has finished and is no longer accepting participants.
Location not clearly listedWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.